(Q38118612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

MicroRNAs targeting EGFR signalling pathway in colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Jitka Mlcochova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Radim Nemecek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Marek Svoboda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Ondrej Slaby

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

2 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1615-1624

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-013-1470-9

4 March 2020

exact match

0 references

cites work

Pdcd4, a colon cancer prognostic that is regulated by a microRNA.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Role of miR-143 targeting KRAS in colorectal tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

EGFR antagonists in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

The Evi1, microRNA-143, K-Ras axis in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

FOXO transcription factors at the interface between longevity and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MicroRNA-145 targets YES and STAT1 in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

miR-23a promotes the transition from indolent to invasive colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

STAT1 as a key modulator of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

p53 and microRNA-34 are suppressors of canonical Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

BM-ca is a newly defined type I/II anti-CD20 monoclonal antibody with unique biological properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Molecular biology of the Ets family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Colorectal cancer molecular biology moves into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

ERK1/2 MAP kinases: structure, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

p53 represses c-Myc through induction of the tumor suppressor miR-145

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Hyperactive Ras in developmental disorders and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

21 January 2018

EGFR-targeted therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MicroRNA function in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

miR-129 regulates cell proliferation by downregulating Cdk6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MicroRNA-223 regulates FOXO1 expression and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Clinical significance of miR-22 expression in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1470-9

Mammalian target of rapamycin: a central node of complex signaling cascades

21 January 2018

1 reference

12 December 2020

miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression

1 reference

12 December 2020

Prognostic Values of microRNAs in Colorectal Cancer

1 reference

12 December 2020

Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells

1 reference

12 December 2020

MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells

1 reference

12 December 2020

KRAS up-regulates the expression of miR-181a, miR-200c and miR-210 in a three-dimensional-specific manner in DLD-1 colorectal cancer cells.

1 reference

12 December 2020

RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets

1 reference

12 December 2020

Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors

1 reference

12 December 2020

Clinical, pathologic, and molecular features of early-onset colorectal carcinoma

1 reference

12 December 2020

MicroRNA miR-125b is a prognostic marker in human colorectal cancer

1 reference

12 December 2020

microRNA-181a is associated with poor prognosis of colorectal cancer

1 reference

12 December 2020

Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro

1 reference

12 December 2020

Over- and under-expressed microRNAs in human colorectal cancer.

1 reference

12 December 2020

MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers.

1 reference

12 December 2020

Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression

1 reference

12 December 2020

A comprehensive pathway map of epidermal growth factor receptor signaling

1 reference

12 December 2020

Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer.

1 reference

12 December 2020

10.1007/S00432-013-1470-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23817698%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference